Details for Patent: 11,576,878
Which drugs does patent 11,576,878 protect, and when does it expire?
Patent 11,576,878 protects ARYNTA and is included in one NDA.
This patent has eighteen patent family members in seventeen countries.
Summary for Patent: 11,576,878
| Title: | Oral solutions comprising lisdexamfetamine salts |
| Abstract: | Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions. |
| Inventor(s): | Georgios LIOLIOS, Ioannis Psarrakis |
| Assignee: | Adalvo Ltd |
| Application Number: | US16/961,784 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 11,576,878
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | ARYNTA | lisdexamfetamine dimesylate | SOLUTION;ORAL | 219847-001 | Jun 16, 2025 | RX | Yes | Yes | 11,576,878 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,576,878
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020416052 | ⤷ Start Trial | |||
| Brazil | 112022012986 | ⤷ Start Trial | |||
| Canada | 3165248 | ⤷ Start Trial | |||
| Chile | 2022001792 | ⤷ Start Trial | |||
| Colombia | 2022010594 | ⤷ Start Trial | |||
| Cyprus | 1125630 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
